Tatva Chintan Pharma Chem Reaches All-Time Low Amid Ongoing Financial Struggles
Tatva Chintan Pharma Chem has faced notable volatility, hitting an all-time low and experiencing a three-day losing streak. The stock has underperformed in the chemicals sector, with significant declines over various time frames. Financial metrics reveal ongoing challenges, including declining sales and operating profit, alongside a low return on capital employed.
Tatva Chintan Pharma Chem has experienced significant volatility today, reaching an all-time low of Rs. 620.6. The stock has underperformed the chemicals sector, declining by 3.07% and marking a consecutive three-day losing streak with a total drop of 12.16%. Opening with a gap down of 2.62%, the stock hit an intraday low of Rs. 620.6, reflecting a broader trend of weakness.Over various time frames, Tatva Chintan's performance has been notably poor. In the past day, it fell by 1.99%, while over the past week and month, it has seen declines of 9.67% and 9.62%, respectively. The three-month performance shows a significant drop of 29.21%, and the stock has plummeted 72.49% over the last three years.
Financial metrics indicate troubling trends, with net sales declining at an annual rate of 5.62% and operating profit down by 48.11% over the past five years. The company has reported negative results for 12 consecutive quarters, with a return on capital employed (ROCE) at a low 3.43%. Despite a low debt-to-equity ratio of 0.04, the stock's valuation remains high compared to peers, further complicating its market position.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
